Good-faith evaluation
As of the time of writing, retatrutide has not received marketing authorisation in the United Kingdom
Select Your Current Weight (lbs.) 135 Potential Weight Loss (lbs.) 27 On average, patients lose around 20% of their body weight What to expect on the Journey to a New You Explore this 12-month timeline for a clear roadmap of what to expect on your GLP-1 medication journey
The landmark UK prospective diabetes study (UKPDS) provided the first high-quality evidence that improving glycemic control in those with newly established T2D conclusively reduces rates of microvascular complications and long-term macrovascular disease
When labs, supplies, and monitoring are factored in, the true all-in cost of a properly run telehealth protocol is often comparable to or greater than a Perfect B protocol
(Source: Surgery for Obesity and Related Diseases, 2026) Where GLP-1 Therapy Fits at GoalBMI Wellness This data doesnt argue against GLP-1 therapy it argues for the structured, physician-supervised approach that helps patients stay on treatment long enough to see the results clinical trials demonstrate are achievable